- Home
- ALT vs PPT Comparison
ALT vs PPT Comparison
Compare ALT & PPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- PPT
- Stock Information
- Founded
- ALT 1997
- PPT 1988
- Country
- ALT United States
- PPT United States
- Employees
- ALT N/A
- PPT N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- PPT Finance Companies
- Sector
- ALT Health Care
- PPT Finance
- Exchange
- ALT Nasdaq
- PPT Nasdaq
- Market Cap
- ALT 292.0M
- PPT 356.5M
- IPO Year
- ALT N/A
- PPT N/A
- Fundamental
- Price
- ALT $3.83
- PPT $3.70
- Analyst Decision
- ALT Strong Buy
- PPT
- Analyst Count
- ALT 6
- PPT 0
- Target Price
- ALT $17.40
- PPT N/A
- AVG Volume (30 Days)
- ALT 3.0M
- PPT 156.1K
- Earning Date
- ALT 08-12-2025
- PPT 01-01-0001
- Dividend Yield
- ALT N/A
- PPT 8.84%
- EPS Growth
- ALT N/A
- PPT N/A
- EPS
- ALT N/A
- PPT N/A
- Revenue
- ALT $20,000.00
- PPT N/A
- Revenue This Year
- ALT N/A
- PPT N/A
- Revenue Next Year
- ALT $761,880.20
- PPT N/A
- P/E Ratio
- ALT N/A
- PPT N/A
- Revenue Growth
- ALT N/A
- PPT N/A
- 52 Week Low
- ALT $2.90
- PPT $3.25
- 52 Week High
- ALT $11.16
- PPT $3.72
- Technical
- Relative Strength Index (RSI)
- ALT 51.79
- PPT 54.54
- Support Level
- ALT $3.35
- PPT $3.64
- Resistance Level
- ALT $3.66
- PPT $3.73
- Average True Range (ATR)
- ALT 0.19
- PPT 0.03
- MACD
- ALT 0.07
- PPT 0.00
- Stochastic Oscillator
- ALT 86.18
- PPT 61.11
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About PPT Putnam Premier Income Trust
Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.